Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shapiro, E. T.
Right arrow Articles by Polonsky, K. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shapiro, E. T.
Right arrow Articles by Polonsky, K. S.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Diabetes, Vol 36, Issue 12 1365-1371, Copyright © 1987 by American Diabetes Association


ARTICLES

Insulin secretion and clearance. Comparison after oral and intravenous glucose

ET Shapiro, H Tillil, MA Miller, BH Frank, JA Galloway, AH Rubenstein and KS Polonsky
Department of Medicine, University of Chicago, Pritzker School of Medicine, Illinois 60637.

Insulin secretion and clearance in response to the administration of oral and intravenous glucose was investigated in nine normal men. C-peptide metabolic kinetics were calculated by analysis of individual C-peptide decay curves after the bolus injection of biosynthetic human C-peptide. Glucose was administered to the subjects on three occasions: as a 75-g oral dose, a 75-g i.v. infusion, and an intravenous glucose infusion at a variable rate adjusted to mimic the peripheral glucose levels obtained after the oral glucose load (matching experiment). Glucose, insulin, and C-peptide concentrations were measured for the subsequent 5 h. The glucose level after the oral glucose load (115.9 +/- 2.6 mg/dl, mean +/- SE) closely approximated that after the matching experiment (120.5 +/- 2.5 mg/dl) but was significantly lower than after 75 g i.v. glucose (127.7 +/- 3.4 mg/dl, P less than .05). Analysis of the areas under the peripheral concentration curves (60-360 min) showed that the responses of both insulin (52.7 +/- 5.6 and 46.5 +/- 4.5 pmol.ml-1.300 min-1) and C-peptide (252.7 +/- 27.5 and 267.0 +/- 21.6 pmol.ml-1.300 min-1) were not significantly different after the oral and 75-g i.v. glucose studies, respectively, whereas in the matching experiment, both the insulin (26.1 +/- 3.9 pmol.ml-1.300 min-1) and C-peptide (178.0 +/- 18.9 pmol.ml-1.300 min-1) responses were lower (P less than .05) than in the other two studies. Insulin secretory rates were derived from peripheral C-peptide concentrations with an open two-compartment model and individually derived model parameters. (ABSTRACT TRUNCATED AT 250 WORDS)
Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
J. J. Meier, J. J. Holst, W. E. Schmidt, and M. A. Nauck
Reduction of hepatic insulin clearance after oral glucose ingestion is not mediated by glucagon-like peptide 1 or gastric inhibitory polypeptide in humans
Am J Physiol Endocrinol Metab, September 1, 2007; 293(3): E849 - E856.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
M. Campioni, G. Toffolo, L. T. Shuster, F. J. Service, R. A. Rizza, and C. Cobelli
Incretin effect potentiates beta-cell responsivity to glucose as well as to its rate of change: OGTT and matched intravenous study
Am J Physiol Endocrinol Metab, January 1, 2007; 292(1): E54 - E60.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
M. A. Nauck, B. Baller, and J. J. Meier
Gastric Inhibitory Polypeptide and Glucagon-Like Peptide-1 in the Pathogenesis of Type 2 Diabetes
Diabetes, December 1, 2004; 53(suppl_3): S190 - S196.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
A. Caumo and L. Luzi
First-phase insulin secretion: does it exist in real life? Considerations on shape and function
Am J Physiol Endocrinol Metab, September 1, 2004; 287(3): E371 - E385.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
R. Basu, E. Breda, A. L. Oberg, C. C. Powell, C. Dalla Man, A. Basu, J. L. Vittone, G. G. Klee, P. Arora, M. D. Jensen, et al.
Mechanisms of the Age-Associated Deterioration in Glucose Tolerance: Contribution of Alterations in Insulin Secretion, Action, and Clearance
Diabetes, July 1, 2003; 52(7): 1738 - 1748.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
D. K. Layman, H. Shiue, C. Sather, D. J. Erickson, and J. Baum
Increased Dietary Protein Modifies Glucose and Insulin Homeostasis in Adult Women during Weight Loss
J. Nutr., February 1, 2003; 133(2): 405 - 410.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
D. K. Layman
The Role of Leucine in Weight Loss Diets and Glucose Homeostasis
J. Nutr., January 1, 2003; 133(1): 261S - 267.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
G. I. Uwaifo, E. M. Fallon, J. Chin, J. Elberg, S. J. Parikh, and J. A. Yanovski
Indices of Insulin Action, Disposal, and Secretion Derived From Fasting Samples and Clamps in Normal Glucose-Tolerant Black and White Children
Diabetes Care, November 1, 2002; 25(11): 2081 - 2087.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
G. I. Uwaifo, S. J. Parikh, M. Keil, J. Elberg, J. Chin, and J. A. Yanovski
Comparison of Insulin Sensitivity, Clearance, and Secretion Estimates Using Euglycemic and Hyperglycemic Clamps in Children
J. Clin. Endocrinol. Metab., June 1, 2002; 87(6): 2899 - 2905.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
A. Brandt, M. Katschinski, R. Arnold, K. S. Polonsky, B. Goke, and M. M. Byrne
GLP-1-induced alterations in the glucose-stimulated insulin secretory dose-response curve
Am J Physiol Endocrinol Metab, August 1, 2001; 281(2): E242 - E247.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
A. Cagnacci, A.M. Paoletti, S. Arangino, G.B. Melis, and A. Volpe
Effect of ovarian suppression on glucose metabolism of young lean women with and without ovarian hyperandrogenism
Hum. Reprod., April 1, 1999; 14(4): 893 - 897.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 1987 by the American Diabetes Association.